SmileDirectClub, Inc. SDC recently announced SmileOS, an innovative new treatment planning software. SmileOS enables its affiliate network of state-certified physicians to treat more patients, predict tooth movements more accurately and better visualize their patients’ treatment.
By direction, the proprietary and customized SmileOS treatment planning software outperforms the capabilities of standard solutions used by many of its competitors and helps the company deliver a superior customer experience.
SmileOS will help hundreds of company-affiliated dentists and orthodontists treat a wider range of patients, ensuring more people benefit from SmileDirectClub’s revolutionary telehealth platform for teeth straightening.
Improved processing with SmileOS
SmileOS is powered by artificial intelligence based on data from over 1.5 million transparent aligner treatment plans, all approved and prescribed by SmileDirectClub’s network of affiliated dentists and orthodontists, and delivered through its platform. pioneering form of telehealth for orthodontics. SmileDirectClub doctors use a series of new algorithms to optimize precise tooth movements for a straighter smile.
Image source: Zacks Investment Research
Advances in tooth phasing with SmileOS increase the number of customers who can benefit from SmileDirectClub aligners by increasing the complexity of eligible cases without the use of buttons or attachments. In addition, SmileOS will increase the number of adolescents eligible to receive treatment with SmileDirectClub clear aligners.
More on the news
SmileDirectClub treatment plans are reviewed, finalized, approved and prescribed by a dentist or orthodontist licensed to practice at the client’s site, as has always been the case. SmileDirectClub Club members receive an overview of their doctor-prescribed treatment plan to see how they will achieve the desired smile in an average treatment period of four to six months. After completing treatment with free annual aligner touch-ups, club members can keep their smile on their face with SmileDirectClub’s Lifetime Smile Guarantee, as they purchase retainers every six months and wear them as indicated.
According to a report published in Data Bridge Market Research, the dental software market is expected to experience a CAGR of 8.23% during the forecast period 2021 to 2028. Factors such as greater adoption of dental radiography systems digital, increasing prevalence of dental disorders, increase in aging population, rapid technological advancements, increase in oral health spending, growth in number of dental offices, rapid increase in insurance coverage – Oral disease and favorable government initiatives are expected to drive the market during the forecast period.
Considering the significant market outlook, the introduction of the innovative new treatment planning software from SmileDirectClub seems strategic.
In October 2021, SmileDirectClub presented the innovative large tanks and compact water flossers. The two new water flossers are said to be more effective than dental floss. These add to the company’s premium oral care line and are currently available at Shop.SmileDirectClub.com, Amazon, Walmart, and Walmart.com.
That same month, the company announced that the United States Patent and Trademark Office (USPTO) would grant a patent on its innovative SmileBus concept. The USPTO patent is expected to strengthen the company’s intellectual property as one of the techniques to deliver high-end, affordable and accessible dental care to more people through its telehealth platform.
In September 2021, the company announced its intention to launch its activities in France at the start of the fourth quarter of 2021. The company is expected to launch its premium transparent aligners, telehealth platform and whitening system during its first France SmileShop in Paris, with more sites to follow. The company’s intention to set up in France will mark its entry into its seventh European country.
Share price return
The title underperformed its industry over the past year. It was down 60.6% compared to the industry’s 17.6% growth.
Zacks rank and choice of keys
Currently, SmileDirectClub carries a Zacks Rank # 4 (Sell).
Some actions better classified in the wider medical space are Chemed Company CHE, Corporation of America Holdings Laboratory Where LabCorp LH and Western Pharmaceutical Services, Inc. WST, each carrying a Zacks Rank # 2 (Buy). You can see The full list of today’s Zacks # 1 Rank (Strong Buy) stocks here.
Chemed has a long-term profit growth rate of 7.7%. The company has beaten earnings estimates in three of the past four quarters and missed one, delivering a surprise of 5.6% on average.
Chemed has outperformed its industry over the past year. CHE gained 4.2% against an industry decline of 37.1%.
LabCorp has a long-term profit growth rate of 10.6%. The company has beaten earnings estimates over the past four quarters, delivering an average surprise of 25.7%.
LabCorp has outperformed the industry it belongs to in the past year. LH gained 40.8% compared to the industry’s 17.5% growth.
West Pharmaceutical has a long-term profit growth rate of 27.6%. The company has beaten earnings estimates over the past four quarters, delivering an average surprise of 29.4%.
West Pharmaceutical has outperformed the industry to which it belongs in the past year. WST gained 54.1% against 17.6% growth for the industry.
Zacks’ top picks for leveraging artificial intelligence
This world-changing technology is expected to generate $ 100 billion by 2025. From self-driving cars to analyzing consumer data, people are relying on machines more than ever. Now is the time to capitalize on the 4th industrial revolution. Zacks’ Urgent Special Report Reveals 6 AI Choices Investors Need To Know Today.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.